Naftopidil

DRUG4 trials

Sponsors

Dong-A ST Co., Ltd., Apsen Farmaceutica S.A., Dong-A Pharmaceutical Co., Ltd., Seoul National University Hospital

Conditions

Disorder of Urinary StentHealthyHyperplasiaLower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Phase 1

The Safety/Tolerability and Pharmacokinetics (PKs) of Naftopidil in Korean Healthy Male Volunteers

CompletedNCT00967772

Dong-A ST Co., Ltd.Healthy

Start: 2009-09-30End: 2010-03-31Updated: 2014-10-01

Phase 3

Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS

WithdrawnNCT01203371

Apsen Farmaceutica S.A.Hyperplasia

Start: 2011-01-01End: 2012-01-01Updated: 2026-09-09

The Effect of Naftopidil for the Double-J Stent Discomfort

CompletedNCT01959074

Seoul National University HospitalDisorder of Urinary Stent

Start: 2014-05-31End: 2015-06-30Updated: 2015-12-10

Phase 4

Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

CompletedNCT01922375

Dong-A Pharmaceutical Co., Ltd.Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Start: 2011-12-31End: 2012-09-30Updated: 2013-08-14